Carole Nagant

Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments

Carole Nagant, Betsey Pitts, Kamran Nazmi et al. · Antimicrobial Agents and Chemotherapy · 2012 · 113 citations · Full text

Microbial Pathogens, Peptide Science, Peptide Chemistry +21

Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis

Julie Gorham, Anthony Moreau, Francis Corazza et al. · PLoS ONE · 2020 · 73 citations · Full text

A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer

Carole Nagant, Fanny Ponthieux, Julie Smet et al. · International Journal of Infectious Diseases · 2020 · 63 citations · Full text

Prognostic Biomarkers, Medicine, Acute Care +9

Efficacy of the Combination of Tobramycin and a Macrolide in an <i>I</i> <i>n</i> <i>V</i> <i>itro</i> <i>Pseudomonas aeruginosa</i> Mature Biofilm Model

Marie Tré‐Hardy, Carole Nagant, Naïma El Manssouri et al. · Antimicrobial Agents and Chemotherapy · 2010 · 53 citations · Full text

Discrimination of COVID‐19 From Inflammation‐Induced Cytokine Storm Syndromes Using Disease‐Related Blood Biomarkers

Christoph Kessel, Richard Vollenberg, Katja Masjosthusmann et al. · Arthritis & Rheumatology · 2021 · 51 citations · Full text

Immunodeficiencies, Immunology, Objective Infection +18